A fully validated HPLC–UV method for determination of sulthiame in human serum/plasma samples. (17th November 2020)

• Record Type: Journal Article
• Authors: Madej, Katarzyna; Paprotny, Łukasz; Wianowska, Dorota; Kasprzyk, Joanna; Herman, Małgorzata; Piekoszewski, Wojciech
• Is Part Of: Biomedical chromatography. Volume 35:Number 3(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-11-17
• Subjects: antiepileptic drug -- fully validated HPLC–UV method -- serum/plasma samples -- sulthiame; Chromatographic analysis -- Periodicals; Biology -- Periodicals; Medicine -- Periodicals; Biology -- Periodicals; Chromatography -- methods -- Periodicals; Medicine -- Periodicals; 543.089
• DOI: 10.1002/bmc.5002
• Languages: English
• ISSNs: 0269-3879

Abstract

Abstract: Sulthiame is an old antiepileptic medicine with controversial history, whose effectiveness and safety in use have been stated in some current studies. However, there is still a need for further clinical examinations for confirmation of its usefulness and tolerability in monotherapy and add‐on therapy for epilepsy of various etiologies. A fully validated RP HPLC–UV method for determination of sulthiame in serum/plasma samples using desethylatrazine as the internal standard was developed. The biological fluid was prepared for analysis by a simple precipitation method with acetonitrile. The following validation parameters of the method were determined: selectivity/specificity, linearity range (0.2–50.0 μl/ml, R 2 > 0.9999), limits of detection (0.19 μl/ml) and quantification (0.58 μl/ml), precision (intra‐day CV 1.06% and inter‐day CV 1.25%), extraction recovery (~100%), accuracy (bias, −4.61–0.80%), carryover and ruggedness. Moreover, the stability of the medicine in plasma samples under different storage conditions was also tested. The usability of the method for clinical examinations was checked by analysis of serum samples originating from 19 patients treated with sulthiame. The proposed method is appropriate for determination of sulthiame in serum/plasma samples for drug monitoring purposes, as well as for pharmacokinetic studies.